Product manufactured by Hospira, Inc.

Application Nr Approved Date Route Status External Links
NDA018251 1992-04-17 Intravenous RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage These Solutions Are Indicated For Parenteral Replacement Of Extracellular Losses Of Fluid And Electrolytes, With Or Without Minimal Carbohydrate Calories, As Required By The Clinical Condition Of The Patient.

All Formulated Excipients (0 Total)


Active Ingredients ( 3 Total)